We studied circulating (C)CD34 + cells by flow cytometry in 96 patients with myelodisplastic syndromes (MDS) at diagnosis, and in a subset of 35 cases during follow-up. CCD34 + counts were stratified within both International Prognostic Scoring System (IPSS) and World Health Organization (WHO) categ
Increased apoptosis of circulating T cells in myelodysplastic syndromes
β Scribed by Yumiko Shioi; Hideto Tamura; Norio Yokose; Chikako Satoh; Kazuo Dan; Kiyoyuki Ogata
- Publisher
- Elsevier Science
- Year
- 2007
- Tongue
- English
- Weight
- 353 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0145-2126
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Pluripotent (CFU-MIX), erythroid (BFU-E) and granulocyte/macrophage (CFU-GM) progenitor cells were examined in bone marrow (BM) from 23 patients with myelodysplastic syndromes (MDS). Patients were grouped according to the FAB classification: Refractory anemia (RA), n = 3; RA with ring sideroblasts (
The myelodysplastic syndromes (MDS) are a group of malignancies with poor prognosis and obscure etiology. To better understand the distribution of MDS in the population and help generate etiologic hypotheses, we assessed potential clustering in the incidence of MDS in the state of Connecticut using
## Objective: Systemic sclerosis (ssc) is an autoimmune disease marked by aberrant activation and apoptosis of endothelial cells (ecs) and decreased numbers of circulating angiogenic cells (cacs). the aim of this study was to analyze whether microparticles might link pathologic activation and apopt